Alisha Wainwright

You're listening to When Science Finds a Way.

Now we want to hear from you.

So as you know over here, we love our evidence-based research.

So we have a little survey for you.

We want to know what we should keep doing, maybe start doing, and maybe even stop doing.

It takes just 10 minutes.

It's completely anonymous.

Fill in the survey now for a chance to win a little gift from us.

There's a link in the show notes.

And again, thank you so much for listening to When Science Finds A Way.

Welcome to When Science Finds a Way, a podcast about the science changing the world.

I'm Alicia Wainwright, and on this series, I'm talking to the global experts who are making a difference, as well as the people who have inspired and contributed to their work.

This episode is about ending the world's deadliest infectious disease, tuberculosis, or TB.

TB is contagious and airborne.

In 2024, 10 million people were diagnosed with TB, and it caused over a million deaths.

TB is preventable and curable with the right treatment.

But this is complicated by the emergence of drug-resistant strains of the disease.

These strains are not susceptible to the usual frontline treatment and require special diagnostic tests and drug regimens.

And this is a challenge because the TB burden falls disproportionately on settings and populations in which these resources may not be easily accessible.

Joining me to discuss TV is Professor Salome Charlombus, Group Chief Health Officer at the Orem Institute in South Africa.